Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIntercede Regulatory News (IGP)

Share Price Information for Intercede (IGP)

Share Price is delayed by 15 minutes
Get Live Data
124.00    1.50 (1.22%)
Bid:
123.00
Ask:
125.00
Spread: 2.00 (1.626%)
Market Cap: £74.60m
IGP Live PriceLast checked at - London Stock Exchange

Intraday Intercede Share Chart

Contract Orders and Renewals

8 Jan 2025 07:00

RNS Number : 4778S
Intercede Group PLC
08 January 2025
 

8 January 2025

INTERCEDE GROUP plc

('Intercede', the 'Company' or the 'Group')

 

Contract Orders and Renewals for MyID CMS and Maiden Order for MyID SecureVault

Intercede, the leading cybersecurity software company specialising in digital identities, is pleased to announce continued momentum in the business with further contract orders and renewals worth over $5m in aggregate being signed during the month of December 2024.

These include the following new orders and renewals:

 

· A major licence order MyID CMS from a systems integrator for a new government end client based in Asia. The order is for c$0.9m with associated multi-year support and maintenance of c$0.56m;

 

· For the same client above, the maiden subscription licence order for MyID SecureVault of c$0.5m over a 2-year period;

· A MyID MFA licence subscription order for a leading airline in the Middle East (new logo) through a new partner focussing on airport security screening;

· A MyID MFA licence subscription order for a leading Kuwaiti Bank (new logo) contracted through Intercede's distribution channel in the region; and

· MyID CMS subscription licence order for an American publicly traded, government sponsored enterprise (new logo), contracted through a managed services partner: and

· The following renewals for MyID CMS:

a support and maintenance renewal from a large US Federal Agency in excess of $1.4m;

a support and maintenance renewal from a large US Federal Agency in excess of $1.0m;

a support and maintenance renewal from a key US Federal Agency in excess of $0.15m.

In addition to the above licence orders and renewals, the Company also secured several professional services orders worth, in aggregate, c$0.4m to implement new installations and provide ongoing customer support.

 

These orders, combined with expected additional conversion of the existing pipeline in Q4 FY25, means that the Company now expects financial performance to be ahead of market expectations for FY25* and further underpins confidence looking forward towards FY26 and FY27.

 

Klaas van der Leest, CEO, commented:

 

"We are very pleased to secure new licence orders in the Rest of the World territory (excluding Americas), especially with a new government end client based in Asia which also includes the first subscription licence order for MyID SecureVault.

 

The orders were contracted through Asia's leading cyber security services provider, and once again, underpins our go-to-market strategy.

 

The Group continues to demonstrate its ability to address client needs quickly, efficiently, and commercially as the maiden order for MyID SecureVault shows.

The renewals and services highlight the critical nature of our software once in production and underpins the long tenure of our existing client base".

 

* The Board believes that the current consensus estimates for the year ending 31 March 2025 is revenue of £16.1 million and adjusted EBITDA of £3.3 million.

 

ENQUIRIES

Intercede Group plc

Tel. + 44 (0)1455 558111

Klaas van der Leest

CEO

Nitil Patel

CFO

 

 

 

Cavendish Capital Markets Limited

Tel. + 44 (0)20 7220 0500

Marc Milmo/Fergus Sullivan/Rory Sale

Corporate Finance

Tim Redfern/Ondraya Swanson

ECM

 

About Intercede

Intercede is a cybersecurity software company specialising in digital identities, and its innovative solutions enable organisations to protect themselves against the number one cause of data breach: compromised user credentials.

 

The Intercede suite of products allows customers to choose the level of security that best fits their needs, from Secure Registration and ID Verification to Password Security Management, One-Time Passwords, FIDO and PKI. Uniquely, Intercede provides the entire set of authentication options from Passwords to PKI, supporting customers on their journey to passwordless and stronger authentication environments. In addition to developing and supporting Intercede software, the Group offers professional services and custom development capabilities as well as managing the world's largest password breach database.

 

For over 20 years, global customers in government, aerospace and defence, financial services, healthcare, telecommunications, cloud services and information technology have trusted Intercede solutions and expertise in protecting their mission critical data and systems at the highest level of assurance.

For more information visit: www.intercede.com

 

The information communicated in this announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the company's obligations under Article 17 of MAR.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
CNTDZGGMNNDGKZM
Date   Source Headline
4th Feb 20193:19 pmRNSHolding(s) in Company
17th Dec 201810:19 amRNSBoard Change
26th Nov 20187:00 amRNSHalf-year Report
22nd Oct 20187:00 amRNSGrant of Options
4th Oct 20187:00 amRNSTrading Statement
20th Sep 20187:00 amRNSResult of AGM
4th Sep 20187:00 amRNSDirector/PDMR Shareholding
10th Aug 20187:00 amRNSDirector/PDMR Shareholding
31st Jul 20187:00 amRNSDirector/PDMR Shareholding
10th Jul 20188:00 amRNSDirector/PDMR Shareholding
29th Jun 20184:59 pmRNSPDMR Shareholding
7th Jun 20187:00 amRNSFinal Results
26th Apr 20182:10 pmRNSPDMR Change
25th Apr 20187:00 amRNSDirector/PDMR Shareholding
20th Apr 201812:15 pmRNSPDMR Change
11th Apr 201811:36 amRNSHolding(s) in Company
11th Apr 20187:00 amRNSAppointment of Chief Executive
4th Apr 20187:00 amRNSReceipt of $4.0m Order/Trading Update
29th Mar 20187:00 amRNSDirectorate Change
9th Mar 20187:00 amRNSNew Contract Award
13th Feb 20187:00 amRNSNew Contract Award
4th Dec 20177:00 amRNSContract
30th Nov 20177:00 amRNSNew Contract Award
27th Nov 20177:00 amRNSHalf-year Report
6th Nov 20171:58 pmRNSTrading Update
26th Oct 20177:00 amRNSShare Award
5th Oct 20177:00 amRNSTrading Statement
13th Sep 20173:30 pmRNSResult of AGM
13th Sep 20177:00 amRNSDirectorate Change
25th Aug 20177:00 amRNSIssue of Convertible Loan Notes
1st Aug 20179:07 amRNSTotal Voting Rights
27th Jul 20177:00 amRNSShare Incentive Plan & Issue of Equity
18th Jul 20177:00 amRNSDirector/PDMR Shareholding & TVR
13th Jun 20177:00 amRNSCollaborations with VMWare and Imagination
7th Jun 201712:06 pmRNSHolding(s) in Company
7th Jun 201712:01 pmRNSHolding(s) in Company
7th Jun 20177:00 amRNSFinal Results
6th Jun 20177:00 amRNSLaunch of MyIDaaS
25th May 20177:00 amRNSSchedule 2(g) Disclosure
23rd May 20177:00 amRNSAppointment of Chief Sales Officer
17th May 20177:00 amRNSNon-Executive Director Appointment
9th May 20177:00 amRNSContract Win
8th May 20173:45 pmRNSShare Incentive Plan
8th May 20177:00 amRNSIntercede announces Secure Login for WordPress
5th Apr 20177:00 amRNSTrading Update
31st Mar 20177:00 amRNSListing of Convertible Loan Notes
20th Mar 20177:00 amRNSAppointment of VP, US Gov't & Enterprise Sales
15th Mar 20173:03 pmRNSShare Incentive Plan
9th Mar 20177:00 amRNSAppointment of Adviser
3rd Mar 20177:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.